Skip to main content
Publications
Layton JB , Zhou CK, Danysh HE , Bleachler DC, Ziemiecki R , Dinah J, Yin R, Calingaert B , Hunt PR, Gilsenan AW , Johannes CW . Identifying cohorts of patients with type 2 diabetes mellitus initiating dapagliflozin in three data sources . Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.
Dinh J, Danysh HE , Johannes C , Gutierrez L , Schmid R, Arana A , Kaye JA, Pladevall-Vila M , Garcia de Albeniz X , Hunt PR, Gilsenan A , Beachler DC, Ke Zhou C. Description of acute kidney injury and breast cancer outcome validation processes across three databases . Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.
Danysh HE , Layton B , Beachler DC, Arana A , Pladevall-Vila M , Schmid R, Calingaert B , Ziemiecki R , Hunt PR, Gilsenan A , Johannes C . Validation of acute outcomes among patients with type 2 diabetes mellitus in Medicare: a pilot study . Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 2020.
Musara P, Milford C, Shapley-Quinn MK, Weinrib R , Mutero P, Odoom E, Mgodi NM, Chirenje ZM, Hanif H, Clark MR, Smit J, van der Straten A, Montgomery ET, Quatro Study Team. Preferences and acceptability of vaginal delivery forms for HIV prevention among women, male partners and key informants in South Africa and Zimbabwe: qualitative findings . AIDS Behav. 2020 Jun 25. doi: 10.1007/s10461-020-02949-4
Browne EN, Montgomery ET, Mansfield C , Boeri M, Mange B, Beksinska M, Schwartz JL, Clark MR, Doncel GF, Smit J, Chirenje ZM, van der Straten A. Efficacy is not everything: eliciting women's preferences for a vaginal HIV prevention product using a discrete-choice experiment . AIDS Behav. 2020 May;24(5):1443-51. doi: 10.1007/s10461-019-02715-1
Njue A , Margulis AV , Lyall M, Nuabor W , Marks M, Russell K, Sinha A. Congenital cytomegalovirus: what are the rates of maternal screening, diagnostic amniocentesis, and elective termination? Poster presented at the ID Week 2019; October 4, 2019. Washington, DC.
Patterson BJ, Herring W , van Oorschot D, Curran D, Carrico J , Zhang Y, Ackerson BK, Bruxvoort K, Sy L, Tseng H. Public health and economic impact of adjuvanted recombinant zoster vaccine adoption for a large, integrated delivery network: utilizing real‐world epidemiological data in a budget impact model . Poster presented at the 2019 AMCP NEXUS; October 29, 2019. National Harbor, DC. [abstract] J Manag Care Spec Pharm. 2019 Oct; 25(10-a):S23.